Down-regulation of tumor suppressor PDCD4 expression in endometrium of adenomyosis patients
1Department of gynecology and obstetrics, Shandong university school of medicine, 44#, Wenhua Xi Road, 250012 Jinan, Shandong, P.R. China.
Objective:
Adenomyosis is a common benign gynecological disease which has some malignant behaviors. Programmed cell death 4 (PDCD4) is a newly identified tumor suppressor gene which lowly expresses in various cancers. However, the expression status of PDCD4 in endometrium of adenomyosis patients has not been investigated. The aim of this study is to assess the expression levels of PDCD4 in endometrium of normal controls and adenomyosis patients.
Methods:
The expression of PDCD4 in endometrium of normal controls and eutopic or ectopic endometrium of patients with adenomyosis was evaluated with quantitative real-time PCR, western blot and immunohistochemistry. In addition, the levels of serum estradiol and progesterone in normal controls and adenomyosis patients were detected using electrochemiluminescence immunoassay.
Results:
The results showed that PDCD4 mainly expressed in the cytoplasma of glandular epithelium of control endometrium and varied during the cycle changes of endometrium, which may be regulated by changing concentrations of progesterone in the menstrual cycle. Compared with the proliferative phase of control endometrium, PDCD4 expression was down-regulated in proliferative phase of eutopic endometrium or ectopic endometrium, and there was no cyclic variation of PDCD4 expression in eutopic endometrium of adenomyosis patients due to progesterone resistance.
Conclusion:
These results suggest that PDCD4 may be involved in the pathogenesis of adenomyosis, which will provide a novel strategy for the early diagnosis and new therapeutic target of adenomyosis.
Insights
Programmed cell death 4 (PDCD4) expression is reduced in adenomyosis endometrium, suggesting its role in disease development. This finding offers potential for early diagnosis and new treatments for adenomyosis.
Area of Science:
- Gynecology
- Oncology
- Molecular Biology
Background:
- Adenomyosis is a common gynecological condition with potential malignant behaviors.
- Programmed cell death 4 (PDCD4) is a tumor suppressor gene with low expression in various cancers.
- PDCD4 expression in adenomyosis endometrium remains uninvestigated.
Purpose of the Study:
- To assess and compare PDCD4 expression levels in the endometrium of normal controls and adenomyosis patients.
- To investigate the potential role of PDCD4 in the pathogenesis of adenomyosis.
Main Methods:
- Quantitative real-time PCR, western blot, and immunohistochemistry were used to evaluate PDCD4 expression.
- Serum estradiol and progesterone levels were measured using electrochemiluminescence immunoassay.
- PDCD4 expression was analyzed in normal, eutopic, and ectopic endometrium.
Main Results:
- PDCD4 was found in the cytoplasm of glandular epithelium and varied cyclically in normal endometrium, potentially regulated by progesterone.
- PDCD4 expression was significantly down-regulated in the proliferative phase of eutopic and ectopic adenomyosis endometrium compared to controls.
- Adenomyosis endometrium showed no cyclic variation in PDCD4 expression, indicating progesterone resistance.
Conclusions:
- PDCD4 may play a role in the pathogenesis of adenomyosis.
- Reduced PDCD4 expression presents a potential biomarker for early adenomyosis diagnosis.
- Targeting PDCD4 could offer a novel therapeutic strategy for adenomyosis.
More Related Videos
07:20Intraoperative Detection of Subtle Endometriosis: A Novel Paradigm for Detection and Treatment of Pelvic Pain Associated with the Loss of Peritoneal Integrity
Published on: December 21, 2012
06:48An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Related Concept Videos
Abnormal Proliferation
Inhibition of Cdk Activity
Oogenesis
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
